"Moving beyond Cas9 may be the secret to reducing CRISPR’s off-target effects," says Garrett Rettig.

We must never forget unmet needs when developing new medicines.

Meet two companies that are advancing pharmaceutical development and manufacture.

Can new tools lower the hurdle of high manufacturing costs for cell and gene therapies?

After a vibrant year of advances in pharmaceutical development and manufacturing technologies, we present The Medicine Maker 2019 Innovation Awards.

Now that Gene therapy's promise has been shown, the industry must focus on improving the manufacturing process and bring down costs.

Free “virtual assistant” tools offer a starting point for formulation – and easier access to regulatory documentation and other enabling information.

Don't forget to nominate the industry's most talented for our 2020 Power List!

Glad tidings of progress and confidence this (conference) season! But let’s not dismiss the emerging skills challenge as “humbug.”

The UK’s CGT Catapult has played a significant role in building the strong advanced therapy ecosystem in the UK, the largest outside the USA.